Correlation Between Cingulate and Algernon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Algernon Pharmaceuticals, you can compare the effects of market volatilities on Cingulate and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Algernon Pharmaceuticals.
Diversification Opportunities for Cingulate and Algernon Pharmaceuticals
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cingulate and Algernon is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of Cingulate i.e., Cingulate and Algernon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate and Algernon Pharmaceuticals
Given the investment horizon of 90 days Cingulate is expected to generate 0.73 times more return on investment than Algernon Pharmaceuticals. However, Cingulate is 1.37 times less risky than Algernon Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest 434.00 in Cingulate on August 28, 2024 and sell it today you would earn a total of 36.00 from holding Cingulate or generate 8.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cingulate vs. Algernon Pharmaceuticals
Performance |
| Timeline |
| Cingulate |
| Algernon Pharmaceuticals |
Cingulate and Algernon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Algernon Pharmaceuticals
The main advantage of trading using opposite Cingulate and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |